MedPath

KiOmed Pharma

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling

Not Applicable
Not yet recruiting
Conditions
Dermal Fillers
Cheek Augmentation
Lip Augmentation
Volume Loss of the Jawline
Facial Wrinkles
Perioral Rhytids
Mid-facial Volume Deficit Related to Aging
Contouring
Midface Contour Deficiencies
Nasolabial Fold Improvement
First Posted Date
2025-03-12
Last Posted Date
2025-03-12
Lead Sponsor
Kiomed Pharma
Target Recruit Count
210
Registration Number
NCT06872359
Locations
🇫🇷

Eurofins Dermscan Pharmascan, Villeurbanne, France

🇵🇱

Centrum Medyczne "Tu Sie Leczy", Gdansk, Poland

Evaluation of Performance and Safety of KIO015 in Face Skin Hydration Improvement

Not Applicable
Active, not recruiting
Conditions
Skin Quality
Interventions
Device: KIO015
First Posted Date
2023-02-28
Last Posted Date
2023-10-19
Lead Sponsor
Kiomed Pharma
Target Recruit Count
80
Registration Number
NCT05747690
Locations
🇫🇷

Eurofins Dermscan Pharmascan, Villeurbanne, France

Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced Symptomatic Knee Osteoarthritis

Phase 4
Active, not recruiting
Conditions
Osteoarthritis, Knee
Interventions
Device: KiOmedine® CM-Chitosan
Device: Synvisc-One®
First Posted Date
2022-01-31
Last Posted Date
2023-03-08
Lead Sponsor
Kiomed Pharma
Target Recruit Count
104
Registration Number
NCT05214807
Locations
🇧🇪

Hip and Knee Unit, Ghent, Belgium

sAfety PerfoRmance chitOsan osteOarthritis ViscosupplEmentation

Not Applicable
Conditions
Knee Osteoarthritis
Interventions
Device: Investigational device coded KIO014
Device: Durolane(r) as control device
First Posted Date
2018-09-20
Last Posted Date
2018-09-21
Lead Sponsor
Kiomed Pharma
Target Recruit Count
100
Registration Number
NCT03679208
© Copyright 2025. All Rights Reserved by MedPath